000 | 01907 a2200529 4500 | ||
---|---|---|---|
005 | 20250515123629.0 | ||
264 | 0 | _c20081118 | |
008 | 200811s 0 0 eng d | ||
022 | _a1552-5783 | ||
024 | 7 |
_a10.1167/iovs.07-1494 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMineo, Jean-François | |
245 | 0 | 0 |
_aUsing human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice. _h[electronic resource] |
260 |
_bInvestigative ophthalmology & visual science _cNov 2008 |
||
300 |
_a4738-45 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
650 | 0 | 4 |
_aAntigens, CD20 _xbiosynthesis |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCerebrum |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aInjections |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 | _aNeoplasms, Experimental |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aVitreous Body |
700 | 1 | _aScheffer, Aymeric | |
700 | 1 | _aKarkoutly, Céline | |
700 | 1 | _aNouvel, Lisa | |
700 | 1 | _aKerdraon, Olivier | |
700 | 1 | _aTrauet, Jacques | |
700 | 1 | _aBordron, Anne | |
700 | 1 | _aDessaint, Jean-Paul | |
700 | 1 | _aLabalette, Myriam | |
700 | 1 | _aBerthou, Christian | |
700 | 1 | _aLabalette, Pierre | |
773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 49 _gno. 11 _gp. 4738-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1167/iovs.07-1494 _zAvailable from publisher's website |
999 |
_c18037648 _d18037648 |